|
Our objective was to evaluate physicians’ perspectives on the clinical utility of pharmacogenetic (PGx) testing in kidney, liver, heart, and lung transplantation (KLHLâ€Tx).
A 36â€question webâ€based survey was developed and administered to medical and surgical directors of US KLHLâ€Tx centers.
|